Tag Archives: Controlled Substances

DEA Slashes Opioid Manufacturing Quotas for 2019

In a joint statement by the U.S. Department of Justice and the Drug Enforcement Administration, the government announced continued efforts to tackle the opioid crisis by reducing the quantity of controlled substances permitted to be manufactured next year. The proposal decreases the 2019 Aggregate Production Quotas (APQ) for six of the most frequently misused opioids … Continue Reading

Alleged Failure to Report Suspicious Orders Leads to Suspension

On May 2, 2018, the DEA issued an Order to Show Cause and Immediate Suspension of Registration (the “Order”) against Morris & Dickson Co., LLC (“M&D”), a drug distributor based in Louisiana with pharmacy customers in 7 states. The DEA has two main allegations against M&D: M&D failed to maintain effective controls against division of … Continue Reading

Enforcement Initiatives Just One of the Topics at the Summit on Controlled Substances

          I am pleased to be part of the roundtable panel, “Update on State and FederalĀ Enforcement Initiatives,” at the American Conference Institute’s Summit on Controlled Substances, being held January 29-31 at the Washington Plaza Hotel in Washington, D.C. Conference faculty will discuss current challenges, benchmark strategies, and how to prepare for … Continue Reading
LexBlog